Optimal treatment for idiopathic pulmonary fibrosis

被引：0
|
作者：
Maher, T. M. [1 ]
Wells, A. U. [1 ]
机构：
[1] Royal Brompton Hosp, Dept Resp Med, Interstitial Lung Dis Unit, London SW3 6NP, England
来源：
THORAX | 2008年 / 63卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：1120 / 1121
页数：4
相关论文
共 50 条
  • [1] Optimal treatment for idiopathic pulmonary fibrosis Reply
    Williams, T. J.
    Wilson, J. W.
    [J]. THORAX, 2008, 63 (12) : 1121 - 1121
  • [2] Treatment of idiopathic pulmonary fibrosis
    Daniels, Craig E.
    Ryu, Jay H.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 27 (06) : 668 - 676
  • [3] Treatment of idiopathic pulmonary fibrosis
    Valeyre, Dominique
    Dion, Genevieve
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2010, 194 (02): : 367 - 381
  • [4] TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    NICOD, LP
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 125 (10) : 483 - 488
  • [5] Treatment of Idiopathic Pulmonary Fibrosis
    Abuserewa, Sherif T.
    Duff, Richard
    Becker, Gregory
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [6] THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    WINTERBAUER, RH
    [J]. CHEST, 1991, 100 (01) : 233 - 235
  • [7] Treatment of Idiopathic Pulmonary Fibrosis
    Carlos, William G.
    Strek, Mary E.
    Wang, Tisha S.
    Patel, Harin
    Raghu, Ganesh
    Wilson, Kevin C.
    Thomson, Carey C.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (01) : 115 - 117
  • [8] IDIOPATHIC PULMONARY FIBROSIS Underestimating treatment benefit of lung transplantation for idiopathic pulmonary fibrosis
    Riddell, P.
    Eaton, D.
    Miller, A. B.
    Wells, A. U.
    Egan, J. J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [9] Recognition and Treatment of Idiopathic Pulmonary Fibrosis
    Laurent P. Nicod
    [J]. Drugs, 1998, 55 : 555 - 562
  • [10] Pamrevlumab for the treatment of idiopathic pulmonary fibrosis
    Sgalla, Giacomo
    Franciosa, Claudia
    Simonetti, Jacopo
    Richeldi, Luca
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (08) : 771 - 777
12345